HEALTHALLAFRICA
South Africa: New Shingles Vaccine to Be Launched in SA Private Sector, but Affordability May Limit Access
A new, more effective shingles vaccine called Shingrix, available in the US for ten years, is set to launch in South Africa's private sector pharmacies. However, it is unlikely to be available in the public healthcare system soon due to affordability concerns.
Mentioned
Related Signal
Adjacent reporting
- What will it take to get a vaccine for the Ebola strain driving the current outbreak?
- Ebola vaccine for Bundibugyo strain could take months before human trials
- What will it take to get a vaccine for the Ebola strain driving the current outbreak?
- 'No vaccine... no treatment': Experts raise alarm over rare strain of Ebola spreading through Africa as WHO declares global health emergency
- A New Hantavirus Vaccine Is in the Works